Sterling, KS, United States of America

Gene H Zaid

This inventor holds 56 USPTO granted patents and 29 published patent applications, plus 3 CIPO patents and 3 EPO patents, primarily in Therapeutic Compositions (CPC class A61K). Top assignees: Ankh Life Sciences Limited, Jacam Chemicals, LLC, Jacam Chemical Company 2013, LLC. Active years: 1999-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gene H Zaid. Retrieved from https://idiyas.com/inventor/gene-h-zaid

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 56 

% Patents Active = 76.8

 

 

Average Co-Inventor Count = 2.2

ph-index = 8

Forward Citations = 289(Granted Patents)

Forward Citations (Not Self Cited) = 207(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Sterling, KS (US) (1999 - 2024)
  • Hutchinson, KS (US) (2020 - 2024)

Company Filing History:


Years Active: 1999-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Thymoquinone
Harmaline
COVID-19
Therapeutic Agents
Curcumin
Harmine
Plasma Cell Neoplasm
Nutritional Supplements
Corrosion Inhibitors
Polyepoxy Succinic Acid
Oil Field Uses
Human Cancers
56 patents (USPTO):Explore Patents

Title: Gene H Zaid: A Pioneer in Therapeutic Innovations

Introduction

Gene H Zaid is a prolific inventor based in Sterling, Kansas, holding an impressive portfolio of 55 patents. His work primarily focuses on therapeutic agents, especially in the fields of oncology and antiviral treatments. His innovations embody a synthesis of complex compounds aimed at addressing critical health challenges.

Latest Patents

Among his latest patents, one notable invention is titled "Therapeutic agents and uses thereof." This patent details human therapeutic compositions that consist of compounds featuring a plurality of fused polycyclic moieties paired with a linker moiety. In specific embodiments, these reactive products emerge from the combination of aldehyde and harmaline components. Notably, these compositions exhibit anti-cancer properties, demonstrating effectiveness against lymphoma, leukemia, and various solid tumor cell lines.

Another significant patent involves the "Inhibition of COVID-19 virus by formulations containing curcumin, harmine, and isovanillin." This innovation outlines a method for treating human subjects exposed to SARS-CoV-2, the virus responsible for COVID-19. The multi-component antiviral formulation includes curcumin, harmine, and isovanillin. This formulation shows promising results in both human applications and cell-based assays aimed at combating the virus.

Career Highlights

Gene has had an impactful career collaborating with esteemed companies like Ankh Life Sciences Limited and Jacam Chemicals, L.L.C. His expertise in medicinal chemistry and pharmacology has allowed him to contribute significantly to advancements in therapeutic science.

Collaborations

Throughout his career, Gene has worked alongside talented individuals, including Beth Ann Wolf and Thomas W Burgoyne. These collaborations have undoubtedly enriched his innovative processes, fostering a creative environment conducive to the development of groundbreaking therapies.

Conclusion

Gene H Zaid exemplifies the spirit of innovation, with a commitment to developing therapeutic solutions that address some of today’s most pressing medical challenges. His contributions to the fields of oncology and antiviral treatments mark him as a key figure in modern medicinal advancements. Through his patented inventions, Gene continues to pave the way for future research and improvements in human health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…